scispace - formally typeset
J

Jason E. McDermott

Researcher at Pacific Northwest National Laboratory

Publications -  150
Citations -  10011

Jason E. McDermott is an academic researcher from Pacific Northwest National Laboratory. The author has contributed to research in topics: Proteomics & Gene. The author has an hindex of 41, co-authored 142 publications receiving 7457 citations. Previous affiliations of Jason E. McDermott include United States Department of Energy & Institute for Systems Biology.

Papers
More filters
Journal ArticleDOI

Proteogenomic characterization of human colon and rectal cancer

Bing Zhang, +64 more
- 18 Sep 2014 - 
TL;DR: Integrated proteogenomic analysis provides functional context to interpret genomic abnormalities and affords a new paradigm for understanding cancer biology.
Journal ArticleDOI

The Genomes of Oryza sativa: a history of duplications.

Jun Yu, +134 more
- 01 Feb 2005 - 
TL;DR: A more inclusive new approach for analyzing duplication history is introduced here, which reveals an ancient whole-genome duplication, a recent segmental duplication on Chromosomes 11 and 12, and massive ongoing individual gene duplications.
Journal ArticleDOI

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

TL;DR: A view of how the somatic genome drives the cancer proteome and associations between protein and post-translational modification levels and clinical outcomes in HGSC is provided.
Journal ArticleDOI

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors

TL;DR: The authors show that CD39 and CD103 mark a subset of tumor-infiltrating CD8 T cells that are tumor-reactive and exhibit characteristics of exhausted or tissue-resident memory T cells, which may lead to future adoptive T-cell cancer therapies.
Journal ArticleDOI

Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.

Suhas Vasaikar, +82 more
- 02 May 2019 - 
TL;DR: Comparative proteomic and phosphoproteomic analysis of paired tumor and normal adjacent tissues produced a catalog of colon cancer-associated proteins and phosphosites, including known and putative new biomarkers, drug targets, and cancer/testis antigens, which suggested glycolysis as a potential target to overcome the resistance of MSI-H tumors to immune checkpoint blockade.